TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - VERTEX PHARMACEUTICALS Stock
Certificat
DE000SY0UFG3
| Market Closed - Boerse Frankfurt Warrants 03:48:38 2024-07-11 pm EDT | ||
| 9.46 EUR | -1.56% |
|
| Current month | -19.03% | ||
| 1 month | -9.78% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 9.32 | -3.02% |
| 24-07-10 | 9.61 | -3.22% |
| 24-07-09 | 9.93 | -3.69% |
| 24-07-08 | 10.31 | -6.61% |
| 24-07-05 | 11.04 | -0.99% |
Real-time Boerse Frankfurt Warrants
Last update July 11, 2024 at 03:48 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | 
Société Générale
|
| WKN | SY0UFG |
| ISIN | DE000SY0UFG3 |
| Date issued | 2024-05-24 |
| Strike | 591.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 13.74 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.18 € |
|---|---|
| Lowest since issue | 9.21 € |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
492.1
USD
Average target price
473.1
USD
Spread / Average Target
-3.87%
- Stock Market
- Certificates
- Certificat
